- Home
- About
- Section Advisors
- Meet Our Field Medical Affairs Team
- Speakers Bureau
- Supporting Organizations
- Contact Us
- PsychU For You
- Topics
- Mental Health Disorders
- Agitation
- Bipolar Disorder
- Depression
- Pseudobulbar Affect (PBA)
- PTSD/Trauma
- Schizophrenia
- Substance Use Disorders
- Topics of Interest
- Care Coordination
- Digital Health
- Diversity, Equity, & Inclusion
- Health Care Policy, Quality & Payer Administration
- Long-Term Care
- Stigma
- Suicide Awareness
- Wellness
- Events
- Content
- Infographics
- Learning Tracks
- Podcasts
- Shareable/Downloadable Content
- Videos
- PsychUSim
- PsychU Roleplay
- Frameworks In Health & Quality Resources
- Mental Health System Guidebooks
- Psychiatric Scales
- Psychopharmacology
- Supporting Organizations
Thank You For Attending Today’s Webinar
Please tell us what you thought about today’s presentation by taking the survey below:
About This Event
Behavioral Health Quality Trends Affecting Payers
The evolving trends of mental healthcare quality measures have a marked impact on payers. Join Molly Burich and Madeline Shurtleff in this discussion that will review current behavioral health quality measures, social determinations of health, and the outcome each has on payers.
Featuring
Molly Burich, (OPDC)
Senior Director, Reimbursement & Health Policy, Government Affairs, Otsuka America Pharmaceutical, Inc.
Madeline Shurtleff, PharmD (OPDC)
Managed Market Liaison
MoreDr. Shurtleff is a clinical pharmacist with experience in managed care and retail pharmacy. She has extensive knowledge in Medicaid and Medicare pharmacy operations and regulatory requirements. Dr. Shurtleff received her Doctor of Pharmacy (PharmD), Business Minor, and Leadership Minor from the University of Rhode Island. She is a licensed pharmacist in Illinois and Arizona.Molly Burich & Madeline Shurtleff are employees of Otsuka American Pharmaceutical Development & Commercialization, Inc. (OPDC)
Related Events
Registration
Related Resources
-
Treatment Considerations For Agitation In Alzheimer’s Dementia
Infographic February 13, 2025The Investigate/Plan/Act approach to Agitation evaluation, management, and prevention.
-
Digital Dialogue Series Part 2
Interview February 10, 2025Digital Therapeutics are health software that treat or alleviate a condition by generating and delivering an intervention. This mini series aims to deepen our understanding of this innovation.
-
Incorporating Digital Therapeutics into the Patient Journey
On-Demand Webinar February 7, 2025Join us for an insightful webinar exploring digital therapeutics (DTx) as innovative, nonpharmacologic treatment options for mental health conditions.
Join today for instant access to all PsychU content, events, and more!
Membership is free!
"*" indicates required fields
Join PsychU Today to receive a wide array of tools and benefits
- Join our multidisciplinary community that is improving mental health care… together
- Quickly learn more about the topics you're interested in
- Access an award-winning library of on-demand mental health resources
- Gain key insights from industry expert & thought leaders
Stay Connected: